• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Genet . Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Nat Genet


. 2022 Jul 25.
doi: 10.1038/s41588-022-01131-x. Online ahead of print.
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection


Scott B Biering[SUP] #[/SUP][SUP] 1 [/SUP], Sylvia A Sarnik[SUP] #[/SUP][SUP] 2 3 [/SUP], Eleanor Wang[SUP] 2 3 [/SUP], James R Zengel[SUP] 4 [/SUP], Sarah R Leist[SUP] 5 [/SUP], Alexandra Schäfer[SUP] 5 [/SUP], Varun Sathyan[SUP] 2 3 [/SUP], Padraig Hawkins[SUP] 6 [/SUP], Kenichi Okuda[SUP] 6 [/SUP], Cyrus Tau[SUP] 2 3 [/SUP], Aditya R Jangid[SUP] 2 3 [/SUP], Connor V Duffy[SUP] 7 [/SUP], Jin Wei[SUP] 8 9 [/SUP], Rodney C Gilmore[SUP] 6 [/SUP], Mia Madel Alfajaro[SUP] 8 9 [/SUP], Madison S Strine[SUP] 8 9 [/SUP], Xammy Nguyenla[SUP] 1 [/SUP], Erik Van Dis[SUP] 10 [/SUP], Carmelle Catamura[SUP] 11 [/SUP], Livia H Yamashiro[SUP] 1 10 [/SUP], Julia A Belk[SUP] 7 [/SUP], Adam Begeman[SUP] 10 [/SUP], Jessica C Stark[SUP] 12 [/SUP], D Judy Shon[SUP] 12 [/SUP], Douglas M Fox[SUP] 1 10 [/SUP], Shahrzad Ezzatpour[SUP] 13 [/SUP], Emily Huang[SUP] 6 14 [/SUP], Nico Olegario[SUP] 6 14 [/SUP], Arjun Rustagi[SUP] 15 [/SUP], Allison S Volmer[SUP] 6 [/SUP], Alessandra Livraghi-Butrico[SUP] 6 [/SUP], Eddie Wehri[SUP] 16 [/SUP], Richard R Behringer[SUP] 17 [/SUP], Dong-Joo Cheon[SUP] 18 [/SUP], Julia Schaletzky[SUP] 16 [/SUP], Hector C Aguilar[SUP] 13 [/SUP], Andreas S Puschnik[SUP] 19 [/SUP], Brian Button[SUP] 6 14 [/SUP], Benjamin A Pinsky[SUP] 15 20 [/SUP], Catherine A Blish[SUP] 15 19 [/SUP], Ralph S Baric[SUP] 5 [/SUP], Wanda K O'Neal[SUP] 6 [/SUP], Carolyn R Bertozzi[SUP] 12 21 [/SUP], Craig B Wilen[SUP] 8 9 22 [/SUP], Richard C Boucher[SUP] 6 [/SUP], Jan E Carette[SUP] 4 [/SUP], Sarah A Stanley[SUP] 1 10 [/SUP], Eva Harris[SUP] 23 [/SUP], Silvana Konermann[SUP] 24 25 [/SUP], Patrick D Hsu[SUP] 26 27 28 29 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a range of symptoms in infected individuals, from mild respiratory illness to acute respiratory distress syndrome. A systematic understanding of host factors influencing viral infection is critical to elucidate SARS-CoV-2-host interactions and the progression of Coronavirus disease 2019 (COVID-19). Here, we conducted genome-wide CRISPR knockout and activation screens in human lung epithelial cells with endogenous expression of the SARS-CoV-2 entry factors ACE2 and TMPRSS2. We uncovered proviral and antiviral factors across highly interconnected host pathways, including clathrin transport, inflammatory signaling, cell-cycle regulation, and transcriptional and epigenetic regulation. We further identified mucins, a family of high molecular weight glycoproteins, as a prominent viral restriction network that inhibits SARS-CoV-2 infection in vitro and in murine models. These mucins also inhibit infection of diverse respiratory viruses. This functional landscape of SARS-CoV-2 host factors provides a physiologically relevant starting point for new host-directed therapeutics and highlights airway mucins as a host defense mechanism.
 
Back
Top Bottom